# Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)

Source: https://welltoldgrants.com/grants/par-25-156-limited-competition-high-impact-specialized-innovation/  
Official notice: https://www.grants.gov/search-results-detail/357634

> National Institutes of Health offered grants to colleges and universities. Applications closed on September 28, 2026.

| Field | Value |
|---|---|
| Opportunity number | PAR-25-156 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 28, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.350 |

## Who can apply

- Public and State controlled institutions of higher education

Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-24-272). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

## Questions people ask

### Is PAR-25-156 still open?

No. It closed on September 28, 2026.

### Who can apply for Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)?

Closed September 28, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-25-156?

NIH RePORTER lists 3 projects funded under PAR-25-156 in fiscal 2026, at 3 institutions. The most were at University of California-Irvine, University of Pennsylvania, Albert Einstein College of Medicine.

### Who has won National Center for Advancing Translational Sciences grants before?

The largest recipients over five fiscal years were University of Pittsburgh - of the Commonwealth System of Higher Education, Vanderbilt University Medical Center, Duke University. The program made 867 awards worth $3.1 billion in that time.